Previous Article | Next Article 
Infection and Immunity, July 2000, p. 4174-4179, Vol. 68, No. 7
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
The Abundant Larval Transcript-1 and -2 Genes of
Brugia malayi Encode Stage-Specific Candidate
Vaccine Antigens for Filariasis
William F.
Gregory,1
Agnes K.
Atmadja,2
Judith E.
Allen,1 and
Rick M.
Maizels1,*
Institute of Cell, Animal and Population
Biology, University of Edinburgh, Edinburgh, United
Kingdom,1 and Department of
Parasitology, Faculty of Medicine, University of Indonesia, Jakarta,
Indonesia2
Received 22 February 2000/Returned for modification 3 April
2000/Accepted 23 April 2000
 |
ABSTRACT |
Lymphatic filariasis is a major tropical disease caused by the
mosquito-borne nematodes Brugia and Wuchereria.
About 120 million people are infected and at risk of lymphatic
pathology such as acute lymphangitis and elephantiasis. Vaccines
against filariasis must generate immunity to the infective
mosquito-derived third-stage larva (L3) without accentuating
immunopathogenic responses to lymphatic-dwelling adult parasites. We
have identified two highly expressed genes, designated abundant larval
transcript-1 and -2 (alt-1 and alt-2), from
each of which mRNAs account for >1% of L3 cDNAs. ALT-1 and ALT-2
share 79% amino acid identity across 125 residues, including a
putative signal sequence and a prominent acidic tract. Expression of
alt-1 and alt-2 is initiated midway through
development in the mosquito, peaking in the infective larva and
declining sharply following entry into the host. Humans exposed to
Brugia malayi show a high frequency of immunoglobulin G1
(IgG1) and IgG3 antibodies to ALT-1 and -2, distinguishing them from
adult-stage antigens, which are targeted by the IgG4 isotype.
Immunization of susceptible rodents (jirds) with ALT-1 elicited a 76%
reduction in parasite survival, the highest reported for a single
antigen from any filarial parasite. ALT-1 and the closely related ALT-2
are therefore strong candidates for a future vaccine against human filariasis.
 |
INTRODUCTION |
Filarial nematodes are helminth
parasites which are responsible for lymphatic filariasis, a tropical
disease afflicting some 119 million people (26, 28, 34). The
parasites have a complex life cycle in which mosquito-borne infective
third-stage larvae (L3) invade the human body, mature to adult worms,
and produce large numbers of newborn larvae (microfilariae) which must
transit the mosquito vector in order to develop to L3 (16).
Overt disease has a major immunopathologic component, and a prominent
risk of vaccination with filarial antigens is exacerbation of pathology (22, 27, 32). The target of immunopathological reactions, however, is thought to be the long-lived adult worm and not the infective larva (23, 29).
To date, strategies to identify vaccine antigens in filariasis have
relied on serum antibodies to define antigens, whether by comparing
apparently uninfected subjects with infected patients (11)
or by using sera from animals vaccinated with radiation-attenuated parasites (19, 20). Among the antigens so discovered have been several with high levels of similarity to host antigens (such as
muscle proteins), raising an additional specter of autoimmune induction
by vaccination. No recombinant filarial antigen yet tested induces
significant degrees of immunity to challenge infection (21,
30), indicating that an alternative criterion needs to be adopted.
We describe here a molecular biological approach, the analysis of mRNAs
which are highly and selectively expressed by the mosquito-derived
larva at the time that it is competent to infect the mammalian host. We
sought to identify new antigens which are restricted to this stage and
absent from the mature forms thought to evoke immunopathology. We also
wished to discover parasite-specific genes which carry minimal risk of
cross-reaction with host constituents. By using a PCR approach with the
conserved nematode 5'-spliced leader and oligo(dT) (12), we
have previously reported the full-length cDNA sequences of two highly
expressed genes, designated abundant larval transcript-1 and -2 (13). ALT-1 and ALT-2 represent closely related proteins
(79% identity) and are homologous to an abundant immunogen from larvae
of the dog heartworm Dirofilaria immitis (Di-20/22L)
(10) and to proteins from the additional filarial parasites
Onchocerca volvulus (Ov-ALT-1) (15) and
Acanthocheilonema viteae (31). Most recently, the
SLAP (secreted larval acidic protein) produced by O. volvulus larvae (2, 3) has also been shown to be a
member of the ALT family (Y. Wu and A. E. Bianco, personal communication).
Products associated with parasite invasion, which are tightly regulated
and parasite specific, are likely to be essential to the success of
parasitism (2). We describe here two related genes,
expressed strongly at the larval stage, which are prime candidates for
a new vaccine against filarial infection. The alt genes
represent attractive vaccine antigens for three reasons: (i) they are
larva specific in immunological terms; (ii) they are highly expressed,
offering an abundant target; and (iii) they have no known homolog in
the mammalian host.
 |
MATERIALS AND METHODS |
Parasites and infections of mosquitoes and jirds.
Brugia malayi parasites were obtained from TRS Laboratories
and maintained by feeding Aedes aegypti mosquitoes with
microfilariae in blood. Mosquitoes were maintained for up to 12 days
and crushed to recover infective larvae by baermannization
(13). Jirds were infected with 300 infective larvae
intraperitoneally, and peritoneal adult worms and microfilariae were
recovered 3 or more months later (1).
Genomic cloning.
B. malayi genomic DNA was
prepared as described previously (24) and used as the
template for PCR with alt-1- and alt-2-specific primers as follows: alt-1 forward (nucleotides [nt] 101 to
127 of cDNA), GAT GAC GAA TTC GAC GAC GAA TCC TCA; alt-1
reverse (nt 433 to 407 of cDNA), TTG TTT TGC TTG CTT TGT AAG CAT TTA;
alt-2 forward (nt 102 to 128 of cDNA), GAC GAA GAG TTC GAT
GAC TCC GCA GCC; and alt-2 reverse (nt 443 to 417 of cDNA),
GTA GTA TCA AAG ACT GAT TCA TTC CTA.
RT-PCR.
For reverse transcription (RT)-PCR, first-strand
cDNA was produced from total RNA using GeneAmp RT-PCR kits (Applied
Biosystems, Cheshire, U.K.) as previously described (13).
PCR used the alt-1- and alt-2-specific primers on
first-strand cDNA for 35 cycles of 1 min at 99°C, 1 min at 55°C,
and 1.5 min at 72°C.
Expression, antibody production, and Western blotting.
The
predicted mature ALT-1 protein was expressed in the pET29 T vector
(Novagen) as a fusion protein with histidine and 15-amino acid (15-aa)
S tag peptides. The PCR-amplified alt-1 insert was directly
cloned into the T overhang of the plasmid. Expression was induced with
1 mM IPTG (isopropyl-
-D-thiogalactopyranoside) at 37°C
for 3 h. Bacteria were pelleted and sonicated, and the supernatant
was taken for metal-chelating affinity chromatography on His-Bind resin
(Novagen). BALB/c and CBA/Ca mice were immunized with 20 µg of
recombinant ALT-1 (rALT-1) in complete Freund's adjuvant (CFA),
boosted 1 month later, and bled 7 days subsequently. Western blotting
was performed with 6 µg of phosphate-buffered saline-soluble protein
extract from L3, mixed-stage adults, and microfilariae.
ELISA.
Forty human sera from Sulawesi, Indonesia, were
selected for testing. Recombinant Bm-ALT-1 was coated at 1 µg/ml, a
concentration determined to be optimal in a pilot experiment.
Isotype-specific monoclonal antibodies were used as described
previously (18). Recombinant Bm-33, an aspartyl protease
inhibitor (7), was expressed as a fusion protein with
maltose-binding protein (MBP) in the pMAL expression vector. rBm-33 and
bacterially expressed MBP were each used to coat enzyme-linked
immunosorbent assay (ELISA) plates at 1 µg/ml, and anti-MBP responses
were subtracted from those measured for Bm-33/MBP fusion proteins.
Immunization.
Male jirds (Meriones unguiculatus)
were immunized with 75 µg of rALT-1 in CFA subcutaneously or with CFA
alone (six jirds per group). At weeks 32 and 33, boosts were given of
25 µg of rALT-1 in incomplete Freund's adjuvant (IFA) or IFA alone,
and at week 45 a final boost of 7.5 µg in IFA was given. Two
weeks later, all jirds were challenged with 300 larvae of B. malayi introduced intraperitoneally. After 4 weeks, jirds were
euthanized, and parasites were recovered from the peritoneal cavity and
testes. Parasite recoveries and counting were performed without
knowledge of the experimental status of each animal.
Nucleotide sequence accession numbers.
The genomic
nucleotide sequences for alt-1, alt-2a (1,075-bp
band), and alt-2b (1,212-bp band) have been deposited in the GenBank database under accession numbers AF183572, AF183573, and
AF183574, respectively. The cDNA sequence for alt-2 has been
deposited in the GenBank database under accession number U84723.
 |
RESULTS AND DISCUSSION |
Abundance of alt mRNA.
The alt-1 gene
was originally identified as a prominent trans-spliced mRNA
from L3 larvae of B. malayi (13), and
alt-2 was identified as a closely related expressed sequence
tag (EST) from the same stage. Since then, the Filarial Genome Project
has deposited over 18,000 ESTs from all stages of this parasite
(33). Analysis of this database reveals that
alt-1 is represented by 33 of 2,378 ESTs (1.39%) from the
L3, and alt-2 is represented by 67 of 2,378 (2.82%). The
alt-2 and alt-1 transcripts are, respectively,
first and third in abundance among all L3-expressed cDNAs in the EST dataset (J. E. Allen, J. Daub, D. Guilliano, A. McDonnell, M. Lizotte-Waniewski, D. Taylor, and M. Blaxter, submitted for
publication). Remarkably, neither cDNA can be found among the
14,000-plus sequences derived from other points in the life cycle,
implying that alt-1 and alt-2 are expressed at
less than 0.01% of mRNAs in non-L3 stages.
alt-like gene in Caenorhabditis
elegans.
alt-1 and alt-2 cDNA
sequences encode novel proteins each with signal sequences and
N-terminal acidic tracts, which share 79% amino acid identity
(13), and similar proteins have been described in other
filarial species (10, 15, 31). Alignment of these shows that
among the filarial parasites the acidic tract is highly variable, but
the remainder of the protein is conserved (Fig.
1A). Among the predicted protein
sequences from C. elegans deposited in WormPEP, only distant
similarities could be found with low significance (P
0.18), including two genes designated as phospholipase A2.
However, when the complete nucleotide sequence of C. elegans
was searched, a more significant similarity (P < 10
6) was found on cosmid C08A9. This cosmid contains
a short tract corresponding to the second and third exons of
Bm-alt-1/2 and encodes a predicted peptide sequence with
32% amino acid identity with Bm-ALT-1 (Fig. 1A). Moreover, C08A9 shows
exact alignment of all cysteine residues with Bm-ALT-1/2 and includes
introns in identical positions to those determined for
Bm-alt-1/2. Curiously, no upstream reading frame encoding an
acidic domain could be identified in 3 kb 3' of the homologous
sequence.


View larger version (79K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Sequences of B. malayi ALT-1 (U57547) and
ALT-2 (U84723) compared to W. bancrofti ALT-1 (AF084553; R. Sabarinathan and P. Kalikraj, Anna University, Madras, India,
unpublished) and C. elegans cosmid CO8A9. Alignments with
D. immitis and O. volvulus have been published
previously (13, 15). Note that the intron position in
W. bancrofti has not been determined. (B) Evidence for
expression of the C. elegans alt homologue, a 240-bp PCR
product representing cDNA from mixed-stage C. elegans. Note
the 289-bp band representing genomic DNA.
|
|
Although not previously recognized as an open reading frame (and hence
not included in WormPEP), we established that the
C. elegans
gene designated
Ce-alt-1 is expressed in the free-living
organism: amplification of mixed-stage cDNA with
Ce-alt-1-specific
primers gave a band with a size fully
consistent with correct
splicing, as well as a larger band
corresponding to the genomic
copy (Fig.
1B). Sequencing of the cDNA
band confirmed the splicing
of the predicted intron (intron 2). This
may provide a route for
future work aimed at discerning the biological
function of the
ALT
proteins.
Variant intronic sequences for alt-1 and
alt-2.
We amplified genomic PCR products for each gene
to characterize gene structure, compare intronic structure, and design
suitable primers for RT-PCR. Both genes contained two introns, which
show no similarity between the two genes, with intron-exon boundaries conforming closely to the consensus described for Brugia
genes (36). However, two products were observed from genomic
PCR for alt-2 (Fig. 2A), and
this was found to be due to a dimorphism in the second intron of
alt-2 (Fig. 2B). Both alt-2 introns are unusual
in consisting largely of 27- or 46-nt repeat units (Fig. 2B). The
dichotomy in alt-2 is due to the presence of either six or
nine copies of the 46-bp repeat (Fig. 2B), and individual parasites possess either or both isoforms, indicative of a Mendelian
polymorphism.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 2.
(A) PCR of B. malayi genomic DNA amplified
with (track 1) alt-1-specific primers and (track 2)
alt-2-specific primers. Sizes are shown in base pairs. (B)
Schematic of gene structure of alt-1 and two
alt-2 variants, and the repeat motifs found in the
alt-2 introns.
|
|
Stage-specific gene expression.
Expression of alt-1
and alt-2 at different points of the filarial life cycle was
assessed by RT-PCR. Primers designed to span the introns defined above
were used with the stage-specific cDNA libraries prepared by the
Filarial Genome Project. From these, alt-1 expression was
shown to be strictly L3 specific, and alt-2 largely so,
although trace levels of amplification were evident in other stages
(Fig. 3A). To provide greater detail,
freshly prepared first-strand cDNA was taken at daily intervals during development of parasites from the microfilarial stage to the infective larva in A. aegypti vector mosquitoes (Fig. 3B). This showed
that both alt-1 and -2 are switched on between 5 and 6 days following uptake into the mosquito vector and remain
expressed for the duration of tenure in the insect. Similarly,
parasites were recovered following infection of the rodent host
M. unguiculatus (the jird or Mongolian gerbil). Here,
alt-1 expression terminated abruptly on transfer into the
jird; although brief periods of transcription were detected between
days 4 and 8, no subsequent expression could be detected (Fig. 3C).
alt-2 transcription was less rigorously controlled, with
expression continuing for 3 days postinfection and recurring at
intervals over the following 3 weeks.

View larger version (40K):
[in this window]
[in a new window]
|
FIG. 3.
Expression around the life cycle. (A) Library PCR using
alt-1- and alt-2-specific primers on B. malayi cDNA libraries from microfilariae (MF), L2, L3, and adult
male and female parasites. (B) RT-PCR of first-strand cDNA prepared
from B. malayi parasites recovered from mosquitoes on
successive days following feeding of microfilariae to A. aegypti. U, uninfected mosquitoes. (C) RT-PCR of first-strand cDNA
prepared from B. malayi parasites recovered on successive
days following infection of jirds with L3. Day 0, mosquito-derived L3.
(D) Western blot with anti-ALT-1 and protein extracts from B. malayi L3, adult worms, and microfilariae, No reactivity was seen
with normal mouse serum.
|
|
Antibodies to recombinant ALT-1 protein reacted specifically with a
doublet of 20 kDa in soluble extract of L3 on Western
blots (Fig.
3D),
but no reactivity was detectable towards extracts
of microfilariae and
adult stages. Thus, at the protein level,
ALT-1 and -2 are effectively
L3 specific. This concords with the
larva-specific expression of the
related Di20/22L proteins in
D. immitis (
9,
10)
and of the secreted larval acidic protein
of
O. volvulus
(
3), both of which are released from larvae
once they are
cultured under mammalian conditions. Although ALT
proteins have not
been identified on the surface of
B. malayi larvae,
immunoelectron microscopy has revealed intense staining
with
anti-Bm-ALT-1 antibody in the larval glandular esophagus,
implying that
this product may also be stockpiled ready for release
within the
mammalian host (A. E. Bianco, G. Egerton, W. F. Gregory,
R. M. Maizels, and Y. Wu, unpublished
observations).
Human recognition.
The prominence of the alt
transcripts suggests that exposed humans may be serologically reactive
to the ALT proteins. We tested sera from 40 patients resident in a
B. malayi-endemic area of Indonesia, drawn equally from the
two categories of amicrofilaremic and microfilaremic. The former group
will contain both parasite-free individuals and subjects with subpatent
infections; the latter group all have detectable blood-borne
microfilariae. In patients with filariasis, it is well established that
the overwhelming proportion of antibodies to crude adult and
microfilaria-stage antigens are of the IgG4 isotype (14, 18,
25).
Antibodies to rALT-1 protein were found in members of both groups (Fig.
4). Interestingly, the antibody isotypes
are predominantly
IgG1 and IgG3, and no IgG4 is observed. Recombinant
proteins associated
with the adult stage of
B. malayi, such
as Bm33 (
7), are generally
recognized by IgG4 isotype
antibodies (Fig.
4). There is also
a discordance with observations on
the
O. volvulus protein Ov-ALT-2
(86% identical to but
eight amino acids smaller than Ov-ALT-1).
This is constitutively
expressed (
15), and human onchocerciasis
patients have high
levels (95%) of seropositivity, including IgG4.
Thus, in
O. volvulus, ALT may not represent a larva-specific antigen.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 4.
ELISA using 40 human B. malayi filariasis
sera against ALT-1 and Bm-33 proteins. Upper panels show sera from
amicrofilaremic normal subjects where filariasis is endemic; lower
panels show sera from patients with circulating microfilariae.
Horizontal bars in ALT-1 panels represent the mean value + 3 standard deviations of nonendemic control human serum reactions. Values
for Bm-33 represent the net optical density (OD) following subtraction
of readings for each serum against its fusion protein partner, MBP.
|
|
Protective immunization.
B. malayi infects only
certain host species, among them the jird, which has been used as a
model for human filariasis (1). We immunized jirds with four
doses of ALT-1 and challenged them with 300 live L3. Four weeks later,
76% fewer live parasites were recovered from the immunized group
versus the adjuvant-only controls (Fig.
5). This difference was significant
(P < 0.05) by Whitney-Mann nonparametric statistics.
The data reported here indicate greater than 70% protection in jirds
against a challenge infection; this is substantially better than any
previous filarial recombinant antigen reported and is in the range
achieved by vaccination with radiation-attenuated larvae, 44 to 91%
(35). Of the previously tested antigens, paramyosin has
yielded disappointing results (20, 21), while heat shock
protein 70, myosin, and
1-type IV collagen have recently been shown
not to stimulate protective immunity (30). Thus, ALT-1 and
ALT-2 offer the best vaccine candidates yet found for filariasis.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 5.
Immunization of jirds (M. unguiculatus) with
ALT-1. Groups of six jirds were immunized with either ALT-1 in CFA or
CFA alone, boosted with ALT-1 in IFA or IFA alone, and challenged with
300 B. malayi L3. After 28 days, the number of parasites
recovered were counted. Data from individual animals are plotted, with
geometric means shown as bars. The two groups are significantly
different by the Mann-Whitney nonparametric test (P < 0.05).
|
|
Conclusion.
Vaccination against helminth parasite organisms
has proved problematic, both in identifying likely vaccine antigens
from the wide repertoire of antigens expressed and with respect to the immunopathological responses to many of these antigens (22). We report here a new approach, selecting highly expressed,
stage-specific products such as the ALT proteins, which we show are not
present in the mature adult stage. This, coupled with the fact that ALT proteins are parasite-specific products unrelated to any host constituent, renders less likely any adverse consequences of
immunization. There is evidence from two other filarial species to
associate ALT recognition with immunity (8-10, 15), but the
data given here provide the first demonstration of protective immunity
in a susceptible host. The high level of sequence similarity between ALT sequences from B. malayi and W. bancrofti
suggests that there will be immunological cross-protection between
these two species, one of which (W. bancrofti) is
responsible for >90% of human infections but does not infect
laboratory animals.
The human antibody profile supports, in the context of natural
exposure, the concept that ALT-1 is an L3-specific antigen,
as we have
previously shown that responses to L3 overall are less
dominated by
IgG4 (
17). It is notable that both microfilaria-negative
and -positive groups contain individuals seropositive for ALT-1
antibodies. This finding is in keeping with the notion of age-acquired
concomitant immunity, in which exposed individuals gain protection
against new infection while being unable to eradicate the resident
parasites (
4-6). Thus, both normal subjects from
endemic areas
and microfilaria carriers may express protective
antibodies, effectively
negating the search for protective antigens by
comparing antibodies
from "immune" and "susceptible"
individuals; such a comparison
would have excluded ALT-1 from
consideration.
The conservation of
alt genes in all the filarial nematodes
so far studied and the very weak similarity to a single
C. elegans locus imply that ALT products are critical in a
filaria-specific
role. Moreover, this role evidently requires a
remarkably high
degree of expression at the point of initial entry by
parasites
into the mammalian host. If this role is essential to
parasite
survival, neutralization by the immune response may be
sufficient
to ensure protection. Elucidation of the function of the ALT
proteins
and the nature of the response induced by vaccination with
these
antigens should greatly enhance our understanding of the
immunology
of filarial infection and may lead to successful strategies
for
the control of filarial
disease.
 |
ACKNOWLEDGMENTS |
We thank the Wellcome Trust, the Medical Research Council, and
the European Commission for support under the INCO-DC programme.
We also thank Mark Blaxter, David Guiliano, Xing-xing Zang, and Maria
Yazdanbakhsh for discussion and advice and Janice Murray for assistance
with the filarial life cycle. Bm33 cDNA was kindly supplied by S. Dissanayake.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute of
Cell, Animal and Population Biology, University of Edinburgh, West
Mains Road, Edinburgh EH9 3JT, UK. Phone: 44 131 650 5511. Fax: 44 131 650 5450. E-mail: rick.maizels{at}ed.ac.uk.
Editor:
W. A. Petri Jr.
 |
REFERENCES |
| 1.
|
Ash, L. R., and J. M. Riley.
1970.
Development of subperiodic Brugia malayi in the jird, Meriones unguiculatus, with notes on infections in other rodents.
J. Parasitol.
56:969-973[CrossRef][Medline].
|
| 2.
|
Bianco, A. E.,
B. D. Robertson,
Y.-M. Kuo,
S. Townson, and P. Ham.
1990.
Developmentally regulated expression and secretion of a polymorphic antigen by Onchocerca infective-stage larvae.
Mol. Biochem. Parasitol.
39:203-212[Medline].
|
| 3.
|
Bianco, A. E.,
Y. Wu, and R. E. Jenkins.
1995.
Onchocerca spp: a "family" of secreted acidic proteins expressed by infective larvae in blackflies.
Exp. Parasitol.
81:344-354[Medline].
|
| 4.
|
Day, K. P.
1991.
The endemic normal in filariasis: a static concept.
Parasitol. Today
7:341-343[Medline].
|
| 5.
|
Day, K. P.,
W. F. Gregory, and R. M. Maizels.
1991.
Age-specific acquisition of immunity to infective larvae in a Bancroftian filariasis endemic area of Papua New Guinea.
Parasite Immunol.
13:277-290[Medline].
|
| 6.
|
Day, K. P.,
B. Grenfell,
R. Spark,
J. W. Kazura, and M. P. Alpers.
1991.
Age specific patterns of change in the dynamics of Wuchereria bancrofti infection in Papua New Guinea.
Am. J. Trop. Med. Hyg.
44:518-527.
|
| 7.
|
Dissanayake, S.,
M. Xu,
C. Nkenfou, and W. F. Piessens.
1993.
Molecular cloning and serological characterization of a Brugia malayi pepsin inhibitor homolog.
Mol. Biochem. Parasitol.
62:143-146[CrossRef][Medline].
|
| 8.
|
Frank, G. R., and R. B. Grieve.
1991.
Metabolic labeling of Dirofilaria immitis third- and fourth-stage larvae and their excretory-secretory products.
J. Parasitol.
77:950-956[CrossRef][Medline].
|
| 9.
|
Frank, G. R., and R. B. Grieve.
1995.
Purification and characterization of three larval excretory-secretory proteins of Dirofilaria immitis.
Mol. Biochem. Parasitol.
75:221-229.
|
| 10.
|
Frank, G. R.,
C. A. Tripp, and R. B. Grieve.
1995.
Molecular cloning of a developmentally regulated protein isolated from excretory-secretory products of larval Dirofilaria immitis.
Mol. Biochem. Parasitol.
75:231-240.
|
| 11.
|
Freedman, D. O.,
T. B. Nutman, and E. A. Ottesen.
1989.
Protective immunity in Bancroftian filariasis: selective recognition of a 43-kD larval stage antigen by infection-free individuals in an endemic area.
J. Clin. Invest.
83:14-22.
|
| 12.
|
Gems, D. H.,
C. J. Ferguson,
B. D. Robertson,
A. P. Page,
M. L. Blaxter, and R. M. Maizels.
1995.
An abundant, trans-spliced mRNA from Toxocara canis infective larvae encodes a 26 kDa protein with homology to phosphatidylethanolamine binding proteins.
J. Biol. Chem.
270:18517-18522[Abstract/Free Full Text].
|
| 13.
|
Gregory, W. F.,
M. L. Blaxter, and R. M. Maizels.
1997.
Differentially expressed, abundant trans-spliced cDNAs from larval Brugia malayi.
Mol. Biochem. Parasitol.
87:85-95[CrossRef][Medline].
|
| 14.
|
Hussain, R.,
M. Grögl, and E. A. Ottesen.
1987.
IgG antibody subclasses in human filariasis: differential subclass recognition of parasite antigens correlates with different clinical manifestations of infection.
J. Immunol.
139:2794-2798[Abstract].
|
| 15.
|
Joseph, G. T.,
T. Huima, and S. Lustigman.
1998.
Characterization of an Onchocerca volvulus L3-specific larval antigen, Ov-ALT-1.
Mol. Biochem. Parasitol.
96:177-183[CrossRef][Medline].
|
| 16.
|
Kazura, J. W.,
T. B. Nutman, and B. M. Greene.
1993.
Filariasis: immunology and molecular biology of parasitic infections, 3rd ed., p. 473-495.
Blackwell Scientific Publications, Boston, Mass.
|
| 17.
|
Kurniawan, A.,
E. Sartono,
F. Partono,
M. Yazdanbakhsh, and R. M. Maizels.
1998.
Antibody responses to filarial infective larvae are not dominated by the IgG4 isotype.
Parasite Immunol.
20:9-17[Medline].
|
| 18.
|
Kurniawan, A.,
M. Yazdanbakhsh,
R. van Ree,
R. Aalberse,
M. E. Selkirk,
F. Partono, and R. M. Maizels.
1993.
Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis.
J. Immunol.
150:3941-3950[Abstract].
|
| 19.
|
Li, B.-W.,
R. Chandrashekar,
R. M. Alvarez,
F. Liftis, and G. J. Weil.
1991.
Identification of paramyosin as a potential protective antigen against Brugia malayi infection in jirds.
Mol. Biochem. Parasitol.
49:315-324[CrossRef][Medline].
|
| 20.
|
Li, B.-W.,
R. Chandrashekar, and G. J. Weil.
1993.
Vaccination with recombinant filarial paramyosin induces partial immunity to Brugia malayi infection in jirds.
J. Immunol.
150:1881-1885[Abstract].
|
| 21.
|
Li, B.-W.,
S. Zhang,
K. C. Curtis, and G. J. Weil.
1999.
Immune responses to Brugia malayi paramyosin in rodents after DNA vaccination.
Vaccine
18:76-81[CrossRef][Medline].
|
| 22.
|
Maizels, R. M.,
M. Holland,
F. H. Falcone,
X. X. Zang, and M. Yazdanbakhsh.
1999.
Vaccination against helminth parasites: the ultimate challenge for immunologists?
Immunol. Rev.
171:125-148[CrossRef][Medline].
|
| 23.
|
Maizels, R. M., and R. A. Lawrence.
1991.
Immunological tolerance: the key feature in human filariasis?
Parasitol. Today
7:271-276[CrossRef][Medline].
|
| 24.
|
Maizels, R. M.,
B. D. Robertson,
M. L. Blaxter, and M. E. Selkirk.
1991.
Parasite antigens, parasite genes: a laboratory manual for molecular parasitology.
Cambridge University Press, New York, N.Y.
|
| 25.
|
Maizels, R. M.,
E. Sartono,
A. Kurniawan,
M. E. Selkirk,
F. Partono, and M. Yazdanbakhsh.
1995.
T cell activation and the balance of antibody isotypes in human filariasis.
Parasitol. Today
11:50-56[CrossRef][Medline].
|
| 26.
|
Michael, E.,
D. A. P. Bundy, and B. T. Grenfell.
1996.
Re-assessing the global prevalence and distribution of lymphatic filariasis.
Parasitology
112:409-428.
|
| 27.
|
Nutman, T. B.
1989.
Protective immunity in lymphatic filariasis.
Exp. Parasitol.
68:248-252[Medline].
|
| 28.
|
Nutman, T. B. (ed.).
1999.
Lymphatic filariasis.
Imperial College Press, London, U.K.
|
| 29.
|
Ottesen, E. A.
1992.
Infection and disease in lymphatic filariasis: an immunological perspective.
Parasitology
104:S71-S79.
|
| 30.
|
Peralta, M. E.,
K. A. Schmitz, and T. V. Rajan.
1999.
Failure of highly immunogenic filarial proteins to provide host-protective immunity.
Exp. Parasitol.
91:334-340[CrossRef][Medline].
|
| 31.
|
Pogonka, T.,
U. Oberlander,
T. Marti, and R. Lucius.
1999.
Acanthocheilonema viteae: characterization of a molt-associated excretory/secretory 18-kDa protein.
Exp. Parasitol.
93:73-81[CrossRef][Medline].
|
| 32.
|
Selkirk, M. E.,
R. M. Maizels, and M. Yazdanbakhsh.
1992.
Immunity and the prospects for vaccination against filariasis.
Immunobiology
184:263-281[Medline].
|
| 33.
|
The Filarial Genome Project.
1999.
Deep within the filarial genome: an update on progress in the Filarial Genome Project.
Parasitol. Today
15:219-224[CrossRef][Medline].
|
| 34.
|
World Health Organization.
1992.
Lymphatic filariasis: the disease and its control. Fifth Report of the WHO Expert Committee on Filariasis.
World Health Organization, Geneva, Switzerland.
|
| 35.
|
Yates, J. A., and G. I. Higashi.
1985.
Brugia malayi: vaccination of jirds with 60cobalt-attenuated infective stage larvae protects against homologous challenge.
Am. J. Trop. Med. Hyg.
34:1132-1137.
|
| 36.
|
Zang, X. X.,
M. Yazdanbakhsh,
H. Kiang,
M. R. Kanost, and R. M. Maizels.
1999.
A novel serpin expressed by the blood-borne microfilariae of the parasitic nematode Brugia malayi inhibits human neutrophil serine proteinases.
Blood
94:1418-1428[Abstract/Free Full Text].
|
Infection and Immunity, July 2000, p. 4174-4179, Vol. 68, No. 7
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Vanam, U., Pandey, V., Prabhu, P. R., Dakshinamurthy, G., Reddy, M. V. R., Kaliraj, P.
(2009). Evaluation of Immunoprophylactic Efficacy of Brugia malayi Transglutaminase (BmTGA) in Single and Multiple Antigen Vaccination with BmALT-2 and BmTPX for Human Lymphatic Filariasis. Am J Trop Med Hyg
80: 319-324
[Abstract]
[Full Text]
-
Gnanasekar, M., Rao, K. V. N., He, Y.-X., Mishra, P. K., Nutman, T. B., Kaliraj, P., Ramaswamy, K.
(2004). Novel Phage Display-Based Subtractive Screening To Identify Vaccine Candidates of Brugia malayi. Infect. Immun.
72: 4707-4715
[Abstract]
[Full Text]
-
Babayan, S., Ungeheuer, M.-N., Martin, C., Attout, T., Belnoue, E., Snounou, G., Renia, L., Korenaga, M., Bain, O.
(2003). Resistance and Susceptibility to Filarial Infection with Litomosoides sigmodontis Are Associated with Early Differences in Parasite Development and in Localized Immune Reactions. Infect. Immun.
71: 6820-6829
[Abstract]
[Full Text]
-
Tsuji, N., Suzuki, K., Kasuga-Aoki, H., Isobe, T., Arakawa, T., Matsumoto, Y.
(2003). Mice Intranasally Immunized with a Recombinant 16-Kilodalton Antigen from Roundworm Ascaris Parasites Are Protected against Larval Migration of Ascaris suum. Infect. Immun.
71: 5314-5323
[Abstract]
[Full Text]
-
Winter, A. D., Myllyharju, J., Page, A. P.
(2003). A Hypodermally Expressed Prolyl 4-Hydroxylase from the Filarial Nematode Brugia malayi Is Soluble and Active in the Absence of Protein Disulfide Isomerase. J. Biol. Chem.
278: 2554-2562
[Abstract]
[Full Text]
-
Tsuji, N., Suzuki, K., Kasuga-Aoki, H., Matsumoto, Y., Arakawa, T., Ishiwata, K., Isobe, T.
(2001). Intranasal Immunization with Recombinant Ascaris suum 14-Kilodalton Antigen Coupled with Cholera Toxin B Subunit Induces Protective Immunity to A. suum Infection in Mice. Infect. Immun.
69: 7285-7292
[Abstract]
[Full Text]
-
King, C. L., Connelly, M., Alpers, M. P., Bockarie, M., Kazura, J. W.
(2001). Transmission Intensity Determines Lymphocyte Responsiveness and Cytokine Bias in Human Lymphatic Filariasis. J. Immunol.
166: 7427-7436
[Abstract]
[Full Text]
-
Allen, J. E., Daub, J., Guiliano, D., McDonnell, A., Lizotte-Waniewski, M., Taylor, D. W., Blaxter, M.
(2000). Analysis of Genes Expressed at the Infective Larval Stage Validates Utility of Litomosoides sigmodontis as a Murine Model for Filarial Vaccine Development. Infect. Immun.
68: 5454-5458
[Abstract]
[Full Text]